Zentech, Inc. – Trademark Portfolio
Entity Type: 03
Zentech, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZENFUZE. The owner is based in Houston, TX.
14800 St. Mary's Lane
Houston, TX 77079
Showing of trademarks Trademarks
Trademark Classifications
Zentech, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Zentech, Inc. have?
Zentech, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 3 cancelled.
What trademark classes does Zentech, Inc. file in?
Zentech, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Zentech, Inc.'s most well-known trademarks?
Zentech, Inc.'s registered trademark portfolio includes well-known marks such as ZENFUZE. These are among 1 currently registered trademark in the portfolio.
What is Zentech, Inc.'s trademark registration success rate?
Zentech, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.